Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;98:2687-2694

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramani, K.
Right arrow Articles by Klocke, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramani, K.
Right arrow Articles by Klocke, F. J.

(Circulation. 1998;98:2687-2694.)
© 1998 American Heart Association, Inc.


Clinical Investigation and Reports

Contrast Magnetic Resonance Imaging in the Assessment of Myocardial Viability in Patients With Stable Coronary Artery Disease and Left Ventricular Dysfunction

Kishin Ramani, MD; Robert M. Judd, PhD; Thomas A. Holly, MD; Todd B. Parrish, PhD; Vera H. Rigolin, MD; Michele A. Parker, MS; Cathy Callahan; Steven W. Fitzgerald, MD; Robert O. Bonow, MD; Francis J. Klocke, MD

From the Departments of Medicine, Radiology, and Biomedical Engineering and the Feinberg Cardiovascular Research Institute, Northwestern University Medical School, Chicago, Ill.

Correspondence to Robert O. Bonow, MD, Wesley 524, Northwestern University Medical School, 250 E Superior St, Chicago, IL 60611-3008. E-mail r-bonow{at}nwu.edu

Background—The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201Tl imaging and dobutamine echocardiography.

Methods and Results—Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable (P<=0.002). Delayed contrast hyperenhancement also occurred in segments judged nonviable by dobutamine echocardiography (P<=0.03). The presence or absence of hyperenhancement correlated most closely with nonviability and viability, respectively, in segments that were akinetic or dyskinetic under resting conditions (83% concordance with 201Tl in both cases). In segments with resting hypokinesis, 58% of segments showing hyperenhancement were judged viable by 201Tl and may have represented an admixture of scar tissue and viable myocardium.

Conclusions—Delayed (by 3 to 15 minutes) hyperenhancement of Gd-DTPA contrast–enhanced MRI images occurs frequently in dysfunctional areas of the left ventricle in patients with stable CAD. Hyperenhancement is associated with nonviability by rest-redistribution 201Tl scintigraphy and dobutamine echocardiography, particularly in regions exhibiting resting akinesis/dyskinesis. The absence of hyperenhancement correlates with radionuclide and echocardiographic determinations of viability, regardless of resting contractile function.


Key Words: coronary disease • echocardiography • heart failure • magnetic resonance imaging




This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
J M Wilson
Diagnosis and treatment of acquired coronary artery disease in adults
Postgrad. Med. J., July 1, 2009; 85(1005): 364 - 365.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
C. Knackstedt, P. Schauerte, and P. Kirchhof
Electro-anatomic mapping systems in arrhythmias
Europace, November 1, 2008; 10(suppl_3): iii28 - iii34.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H Bulow, C Klein, I Kuehn, R Hollweck, S G Nekolla, K Schreiber, F Haas, J Bohm, B Schnackenburg, R Lange, et al.
Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease
Heart, September 1, 2005; 91(9): 1158 - 1163.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. Giorgetti, A. Pingitore, B. Favilli, A. Kusch, M. Lombardi, and P. Marzullo
Baseline/Postnitrate Tetrofosmin SPECT for Myocardial Viability Assessment in Patients with Postischemic Severe Left Ventricular Dysfunction: New Evidence from MRI
J. Nucl. Med., August 1, 2005; 46(8): 1285 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. Hunold, T. Schlosser, F. M. Vogt, H. Eggebrecht, A. Schmermund, O. Bruder, W. O. Schuler, and J. Barkhausen
Myocardial Late Enhancement in Contrast-Enhanced Cardiac MRI: Distinction Between Infarction Scar and Non-Infarction-Related Disease
Am. J. Roentgenol., May 1, 2005; 184(5): 1420 - 1426.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
A. Gupta, V. S. Lee, Y.-C. Chung, J. S. Babb, and O. P. Simonetti
Myocardial Infarction: Optimization of Inversion Times at Delayed Contrast-enhanced MR Imaging
Radiology, December 1, 2004; 233(3): 921 - 926.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report
Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Gibbons, U. S. Valeti, P. A. Araoz, and A. S. Jaffe
The quantification of infarct size
J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1533 - 1542.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Wellnhofer, A. Olariu, C. Klein, M. Grafe, A. Wahl, E. Fleck, and E. Nagel
Magnetic Resonance Low-Dose Dobutamine Test Is Superior to Scar Quantification for the Prediction of Functional Recovery
Circulation, May 11, 2004; 109(18): 2172 - 2174.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.R. Underwood, J. J Bax, J. v. Dahl, M. Y Henein, A. C van Rossum, E. R Schwarz, J.-L. Vanoverschelde, E. E.v. d. Wall, and W. Wijns
Imaging techniques for the assessment of myocardial hibernation: Report of a Study Group of the European Society of Cardiology
Eur. Heart J., May 2, 2004; 25(10): 815 - 836.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
L. Van Hoe and M. Vanderheyden
Ischemic Cardiomyopathy: Value of Different MRI Techniques for Prediction of Functional Recovery After Revascularization
Am. J. Roentgenol., January 1, 2004; 182(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. L. Gerber, J. Garot, D. A. Bluemke, K. C. Wu, and J. A.C. Lima
Accuracy of Contrast-Enhanced Magnetic Resonance Imaging in Predicting Improvement of Regional Myocardial Function in Patients After Acute Myocardial Infarction
Circulation, August 27, 2002; 106(9): 1083 - 1089.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
I. Matsunari, J. Taki, and N. Tonami
Sequential Strategy Using Multimodality Viability Tests: Does It Work?
J. Nucl. Med., June 1, 2002; 43(6): 803 - 805.
[Full Text] [PDF]


Home page
Eur Heart JHome page
H. Mahrholdt, A. Wagner, R.M. Judd, and U. Sechtem
Assessment of myocardial viability by cardiovascular magnetic resonance imaging
Eur. Heart J., April 2, 2002; 23(8): 602 - 619.
[Full Text] [PDF]


Home page
CirculationHome page
C. Klein, S. G. Nekolla, F. M. Bengel, M. Momose, A. Sammer, F. Haas, B. Schnackenburg, W. Delius, H. Mudra, D. Wolfram, et al.
Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography
Circulation, January 15, 2002; 105(2): 162 - 167.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. G. Rehwald, D. S. Fieno, E.-L. Chen, R. J. Kim, and R. M. Judd
Myocardial Magnetic Resonance Imaging Contrast Agent Concentrations After Reversible and Irreversible Ischemic Injury
Circulation, January 15, 2002; 105(2): 224 - 229.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. J. W. Sandstede, T. Pabst, M. Beer, C. Lipke, K. Baurle, F. Butter, K. Harre, W. Kenn, W. Voelker, S. Neubauer, et al.
Assessment of Myocardial Infarction in Humans with 23Na MR Imaging: Comparison with Cine MR Imaging and Delayed Contrast Enhancement
Radiology, October 1, 2001; 221(1): 222 - 228.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. Saeed
New Concepts in Characterization of Ischemically Injured Myocardium by MRI
Experimental Biology and Medicine, May 1, 2001; 226(5): 367 - 376.
[Abstract] [Full Text]


Home page
RadiologyHome page
S. J. Flacke, S. E. Fischer, and C. H. Lorenz
Measurement of the Gadopentetate Dimeglumine Partition Coefficient in Human Myocardium in Vivo: Normal Distribution and Elevation in Acute and Chronic Infarction
Radiology, March 1, 2001; 218(3): 703 - 710.
[Abstract] [Full Text]


Home page
CirculationHome page
M. Saeed, G. Lund, M. F. Wendland, J. Bremerich, H.-J. Weinmann, and C. B. Higgins
Magnetic Resonance Characterization of the Peri-Infarction Zone of Reperfused Myocardial Infarction With Necrosis-Specific and Extracellular Nonspecific Contrast Media
Circulation, February 13, 2001; 103(6): 871 - 876.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
O. P. Simonetti, R. J. Kim, D. S. Fieno, H. B. Hillenbrand, E. Wu, J. M. Bundy, J. P. Finn, and R. M. Judd
An Improved MR Imaging Technique for the Visualization of Myocardial Infarction
Radiology, January 1, 2001; 218(1): 215 - 223.
[Abstract] [Full Text]


Home page
RadiologyHome page
K. Lauerma, P. Niemi, H. Hänninen, T. Janatuinen, L.-M. Voipio-Pulkki, J. Knuuti, L. Toivonen, T. Mäkelä, M. A. Mäkijärvi, and H. J. Aronen
Multimodality MR Imaging Assessment of Myocardial Viability: Combination of First-Pass and Late Contrast Enhancement to Wall Motion Dynamics and Comparison with FDG PET-Initial Experience
Radiology, December 1, 2000; 217(3): 729 - 736.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
C. M. Kramer, W. J. Rogers Jr., S. Mankad, T. M. Theobald, D. L. Pakstis, and Y.-L. Hu
Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1835 - 1840.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. S. Fieno, R. J. Kim, E.-L. Chen, J. W. Lomasney, F. J. Klocke, and R. M. Judd
Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing
J. Am. Coll. Cardiol., November 15, 2000; 36(6): 1985 - 1991.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. J. W. Sandstede, C. Lipke, M. Beer, K. Harre, T. Pabst, W. Kenn, S. Neubauer, and D. Hahn
Analysis of First-Pass and Delayed Contrast-Enhancement Patterns of Dysfunctional Myocardium on MR Imaging: Use in the Prediction of Myocardial Viability
Am. J. Roentgenol., June 1, 2000; 174(6): 1737 - 1740.
[Abstract] [Full Text]


Home page
Am. J. Roentgenol.Home page
A. J. Duerinckx
Myocardial Viability Using MR Imaging: Is It Ready for Clinical Use?
Am. J. Roentgenol., June 1, 2000; 174(6): 1741 - 1743.
[Full Text]


Home page
CirculationHome page
R. J. Kim, D. S. Fieno, T. B. Parrish, K. Harris, E.-L. Chen, O. Simonetti, J. Bundy, J. P. Finn, F. J. Klocke, and R. M. Judd
Relationship of MRI Delayed Contrast Enhancement to Irreversible Injury, Infarct Age, and Contractile Function
Circulation, November 9, 1999; 100(19): 1992 - 2002.
[Abstract] [Full Text] [PDF]